5-Pyrimidineacetic acid, 1,2,3,4-tetrahydro-2,4-dioxo-1-beta-D-ribofur anosyl-, methyl ester structure
|
Common Name | 5-Pyrimidineacetic acid, 1,2,3,4-tetrahydro-2,4-dioxo-1-beta-D-ribofur anosyl-, methyl ester | ||
---|---|---|---|---|
CAS Number | 29428-50-0 | Molecular Weight | 316.26 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C12H16N2O8 | Melting Point | 160-162 °C | |
MSDS | N/A | Flash Point | N/A |
Use of 5-Pyrimidineacetic acid, 1,2,3,4-tetrahydro-2,4-dioxo-1-beta-D-ribofur anosyl-, methyl esterMethyl 1,2,3,4-tetrahydro-2,4-dioxo-1-β-D-ribofuranosyl-5-pyrimidineacetate is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
Name | 5-methoxycarbonylmethyluridine |
---|---|
Synonym | More Synonyms |
Description | Methyl 1,2,3,4-tetrahydro-2,4-dioxo-1-β-D-ribofuranosyl-5-pyrimidineacetate is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
---|---|
Related Catalog | |
References |
Melting Point | 160-162 °C |
---|---|
Molecular Formula | C12H16N2O8 |
Molecular Weight | 316.26 |
Exact Mass | 316.09100 |
PSA | 151.34000 |
Storage condition | -20°C |
uridine 5-acetic acid methyl ester |
5-Methoxycarbonylmethyluridine |
mcm(5)u |
5-Mcmu |
methyl 2-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]acetate |
5-(2-methoxy-2-oxoethyl)uridine |
methyl uridine 5-acetate |